CP4 - WEIGHTED AVERAGE CALCULATIONS FOR POPULATING COST-EFFECTIVENESS MODELS- HOW IGNORING THE MODEL’S CLINICAL PATHWAYS CAN SIGNIFICANTLY BIAS THE INCREMENTAL COST-EFFECTIVENESS RATIO (ICER)

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.030
https://www.valueinhealthjournal.com/article/S1098-3015(18)33330-8/fulltext
Section Title :
Section Order : 2200
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33330-8&doi=10.1016/j.jval.2018.09.030
HEOR Topics :
Tags :
Regions :